Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Autologous Bioengineered Internal Anal Sphincter
Therapeutic Area : Gastroenterology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Cellf BIO Begins Phase 1 Clinical Trial of BioSphincter Implant for Fecal Incontinence
Details : The trial will assess the safety of the treatment and the potential initial efficacy of the BioSphincter (Autologous Bioengineered Internal Anal Sphincter) in reducing the number of incontinence episodes in patients with severe fecal incontinence.
Product Name : BioSphincter
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
May 01, 2023
Lead Product(s) : Autologous Bioengineered Internal Anal Sphincter
Therapeutic Area : Gastroenterology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable